Swine Circovirus Vaccine - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510244740

Publication Date:

October 29, 2024

Pages:

117

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Swine circovirus听(PCV) is a group of single-stranded DNA viruses (class II), that is nonenveloped with an unsegmented circular genome.
The global market for Swine Circovirus Vaccine was estimated to be worth US$ 245 million in 2023 and is forecast to a readjusted size of US$ 409 million by 2030 with a CAGR of 7.5% during the forecast period 2024-2030
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Swine Circovirus Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Swine Circovirus Vaccine by region & country, by Type, and by Application.
The Swine Circovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Circovirus Vaccine.
麻豆原创 Segmentation
By Company
Chopper Biology
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Jinyu Bio-Technology
Zoetis
Boehringer Ingelheim
Segment by Type:
Genetic Engineering Vaccine
Killed Vaccines
Segment by Application
Piglets
Adults Pigs
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Swine Circovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Swine Circovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Swine Circovirus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Swine Circovirus Vaccine Product Introduction
1.2 Global Swine Circovirus Vaccine 麻豆原创 Size Forecast
1.2.1 Global Swine Circovirus Vaccine Sales Value (2019-2030)
1.2.2 Global Swine Circovirus Vaccine Sales Volume (2019-2030)
1.2.3 Global Swine Circovirus Vaccine Sales Price (2019-2030)
1.3 Swine Circovirus Vaccine 麻豆原创 Trends & Drivers
1.3.1 Swine Circovirus Vaccine Industry Trends
1.3.2 Swine Circovirus Vaccine 麻豆原创 Drivers & Opportunity
1.3.3 Swine Circovirus Vaccine 麻豆原创 Challenges
1.3.4 Swine Circovirus Vaccine 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Swine Circovirus Vaccine Players Revenue Ranking (2023)
2.2 Global Swine Circovirus Vaccine Revenue by Company (2019-2024)
2.3 Global Swine Circovirus Vaccine Players Sales Volume Ranking (2023)
2.4 Global Swine Circovirus Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Swine Circovirus Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Swine Circovirus Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Swine Circovirus Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Swine Circovirus Vaccine
2.9 Swine Circovirus Vaccine 麻豆原创 Competitive Analysis
2.9.1 Swine Circovirus Vaccine 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Swine Circovirus Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Circovirus Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Genetic Engineering Vaccine
3.1.2 Killed Vaccines
3.2 Global Swine Circovirus Vaccine Sales Value by Type
3.2.1 Global Swine Circovirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Swine Circovirus Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Swine Circovirus Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Swine Circovirus Vaccine Sales Volume by Type
3.3.1 Global Swine Circovirus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Swine Circovirus Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Swine Circovirus Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Swine Circovirus Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Piglets
4.1.2 Adults Pigs
4.2 Global Swine Circovirus Vaccine Sales Value by Application
4.2.1 Global Swine Circovirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Swine Circovirus Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Swine Circovirus Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Swine Circovirus Vaccine Sales Volume by Application
4.3.1 Global Swine Circovirus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Swine Circovirus Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Swine Circovirus Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Swine Circovirus Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Swine Circovirus Vaccine Sales Value by Region
5.1.1 Global Swine Circovirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Swine Circovirus Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Swine Circovirus Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Swine Circovirus Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Swine Circovirus Vaccine Sales Volume by Region
5.2.1 Global Swine Circovirus Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Swine Circovirus Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Swine Circovirus Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Swine Circovirus Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Swine Circovirus Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Swine Circovirus Vaccine Sales Value, 2019-2030
5.4.2 North America Swine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Swine Circovirus Vaccine Sales Value, 2019-2030
5.5.2 Europe Swine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Swine Circovirus Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Swine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Swine Circovirus Vaccine Sales Value, 2019-2030
5.7.2 South America Swine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Swine Circovirus Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Swine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Swine Circovirus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Swine Circovirus Vaccine Sales Value
6.2.1 Key Countries/Regions Swine Circovirus Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Swine Circovirus Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Swine Circovirus Vaccine Sales Value, 2019-2030
6.3.2 United States Swine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Swine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Swine Circovirus Vaccine Sales Value, 2019-2030
6.4.2 Europe Swine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Swine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Swine Circovirus Vaccine Sales Value, 2019-2030
6.5.2 China Swine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Swine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Swine Circovirus Vaccine Sales Value, 2019-2030
6.6.2 Japan Swine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Swine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Swine Circovirus Vaccine Sales Value, 2019-2030
6.7.2 South Korea Swine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Swine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Swine Circovirus Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Swine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Swine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Swine Circovirus Vaccine Sales Value, 2019-2030
6.9.2 India Swine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Swine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Chopper Biology
7.1.1 Chopper Biology Company Information
7.1.2 Chopper Biology Introduction and Business Overview
7.1.3 Chopper Biology Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Chopper Biology Swine Circovirus Vaccine Product Offerings
7.1.5 Chopper Biology Recent Development
7.2 ChengDu Tecbond
7.2.1 ChengDu Tecbond Company Information
7.2.2 ChengDu Tecbond Introduction and Business Overview
7.2.3 ChengDu Tecbond Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 ChengDu Tecbond Swine Circovirus Vaccine Product Offerings
7.2.5 ChengDu Tecbond Recent Development
7.3 Ringpu Biology
7.3.1 Ringpu Biology Company Information
7.3.2 Ringpu Biology Introduction and Business Overview
7.3.3 Ringpu Biology Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Ringpu Biology Swine Circovirus Vaccine Product Offerings
7.3.5 Ringpu Biology Recent Development
7.4 Qilu Animal
7.4.1 Qilu Animal Company Information
7.4.2 Qilu Animal Introduction and Business Overview
7.4.3 Qilu Animal Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Qilu Animal Swine Circovirus Vaccine Product Offerings
7.4.5 Qilu Animal Recent Development
7.5 DHN
7.5.1 DHN Company Information
7.5.2 DHN Introduction and Business Overview
7.5.3 DHN Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 DHN Swine Circovirus Vaccine Product Offerings
7.5.5 DHN Recent Development
7.6 CAVAC
7.6.1 CAVAC Company Information
7.6.2 CAVAC Introduction and Business Overview
7.6.3 CAVAC Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 CAVAC Swine Circovirus Vaccine Product Offerings
7.6.5 CAVAC Recent Development
7.7 Komipharm
7.7.1 Komipharm Company Information
7.7.2 Komipharm Introduction and Business Overview
7.7.3 Komipharm Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Komipharm Swine Circovirus Vaccine Product Offerings
7.7.5 Komipharm Recent Development
7.8 Jinyu Bio-Technology
7.8.1 Jinyu Bio-Technology Company Information
7.8.2 Jinyu Bio-Technology Introduction and Business Overview
7.8.3 Jinyu Bio-Technology Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Jinyu Bio-Technology Swine Circovirus Vaccine Product Offerings
7.8.5 Jinyu Bio-Technology Recent Development
7.9 Zoetis
7.9.1 Zoetis Company Information
7.9.2 Zoetis Introduction and Business Overview
7.9.3 Zoetis Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Zoetis Swine Circovirus Vaccine Product Offerings
7.9.5 Zoetis Recent Development
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Company Information
7.10.2 Boehringer Ingelheim Introduction and Business Overview
7.10.3 Boehringer Ingelheim Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Boehringer Ingelheim Swine Circovirus Vaccine Product Offerings
7.10.5 Boehringer Ingelheim Recent Development
8 Industry Chain Analysis
8.1 Swine Circovirus Vaccine Industrial Chain
8.2 Swine Circovirus Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Swine Circovirus Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Swine Circovirus Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Chopper Biology
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Jinyu Bio-Technology
Zoetis
Boehringer Ingelheim

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.